Peel Therapeutics is a clinical-stage biotech business that is creating drugs to improve the lives of patients. Peel (Hebrew for "elephant") began by focusing on cancer-fighting proteins in elephants, and we rapidly realized the power of leveraging evolution's answers to treat and prevent disease. In addition to producing elephantp53 (EP53) nanoparticles for cancer treatment, our team is expanding new cancer and inflammation medicines derived from nature's superpowers.

Biotechnology

Peel Therapeutics

Org chart

Teams

Offices

Similar companies